Literature DB >> 34652245

A Pilot TB Screening Model in a U.S. Prison Population Using Tuberculin Skin Test and Interferon Gamma Release Assay Based on Country of Origin.

Roxanne P Kerani1,2, Adrienne E Shapiro1,3, Lara B Strick1,4.   

Abstract

The objective of this study was to compare tuberculosis (TB) screening results before and after implementation of a stratified testing strategy screening pilot study, incorporating interferon gamma release assay (IGRA) and tuberculin skin test (TST), based on country of origin. In 2015, the Washington State Department of Corrections began screening people born outside of the United States for TB with IGRA, while U.S.-born people continued screening by TST. Of 405 (75%) foreign-born men screened with IGRA, 403 had valid test results and IGRA screening positivity was 10.4% (N = 42). In contrast, among 5,940 primarily U.S-born men screened with TST, 24 (0.4%) were positive. Overall positivity was 1.05%, similar to TST-only positivity in 2013 (1.05%) and 2014 (0.85%). Incorporating IGRA screening among foreign-born persons was feasible in this state prison system.

Entities:  

Keywords:  IGRA; corrections; immigrants; screening; tuberculosis

Mesh:

Year:  2021        PMID: 34652245      PMCID: PMC8917832          DOI: 10.1089/jchc.19.07.0056

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  28 in total

Review 1.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates.

Authors:  I S Schwartz; P J Bach; B Roscoe; A Majury; W M Hopman; E Ellis; T Garrahan; J Smith; R Barkley; L Panaro; F Jamieson; C Froats; I Gemmill; W L Wobeser
Journal:  Int J Tuberc Lung Dis       Date:  2014-07       Impact factor: 2.373

Review 3.  Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.

Authors:  Adithya Cattamanchi; Rachel Smith; Karen R Steingart; John Z Metcalfe; Anand Date; Courtney Coleman; Barbara J Marston; Laurence Huang; Philip C Hopewell; Madhukar Pai
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

4.  Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2006-07-07

5.  Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection.

Authors:  E De Keyser; F De Keyser; F De Baets
Journal:  Acta Clin Belg       Date:  2014-07-14       Impact factor: 1.264

6.  Comparison of an ESAT-6/CFP-10 peptide-based enzyme-linked immunospot assay to a tuberculin skin test for screening of a population at moderate risk of contracting tuberculosis.

Authors:  Esmaeil Porsa; Lee Cheng; Edward A Graviss
Journal:  Clin Vaccine Immunol       Date:  2007-04-18

7.  Estimated Prevalence of Tuberculosis Infection Among a New York City Clinic Population Using Interferon-gamma Release Assays.

Authors:  Natalie L Stennis; Lisa Trieu; Shama D Ahuja; Tiffany G Harris
Journal:  Open Forum Infect Dis       Date:  2014-07-29       Impact factor: 3.835

8.  Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008.

Authors:  Jennifer A Grinsdale; Shamim Islam; Olivia Chang Tran; Christine S Ho; L Masae Kawamura; Julie M Higashi
Journal:  J Pediatric Infect Dis Soc       Date:  2014-12-15       Impact factor: 5.235

9.  Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay.

Authors:  Puneet Kumar Dewan; Jennifer Grinsdale; Sally Liska; Ernest Wong; Robert Fallstad; L Masae Kawamura
Journal:  BMC Infect Dis       Date:  2006-03-15       Impact factor: 3.090

10.  Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Roque Miramontes; Andrew N Hill; Rachel S Yelk Woodruff; Lauren A Lambert; Thomas R Navin; Kenneth G Castro; Philip A LoBue
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.